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Summary
A simple in vitro experimental system was devised to reflect the in vivo generation of a T cell
anamnestic response so that T cell differentiation couldbe examined at the level of lymphokine
gene expression. Comparison of neonatal and adult T cells revealed that both populations expressed
the genes for interleukin 2 (IL2) and its receptor, but only adult T cells were capable of transcribing
mRNAs for IL-3, IL-4, 11,5, 11,6, interferon y, and granulocyte/macrophage colony-stimulating
factor. However, neonatal T cells couldbe induced to undergo functional differentiation in vitro,
thereby acquiring the capacity to express the lymphokine gene repertoire characteristic for adult
T cells. These data suggest that the T cells generated from neonatal blood by a primary stimulation
in vitro are functionally indistinguishable from the T cells in adult blood that presumably have
undergone primary stimulation in vivo. Therefore, we propose that the term "memory cell"
be applied to those T cells that can be identified by their differentiated state of inducible effector-
lymphokine gene expression.
Memory is the hallmark of an intact immune system,
required for immunity against invading microorganisms
and for the efficacy of vaccination in preventing infections.
Immunologic memory is recognizedby the capacity of a pre-
viously immunized host to respond more rapidly and with
greater intensity to a secondary antigenic challenge (1). The
cellular basis for memory lies in the selective clonal expan-
sion of antigen-specific lymphocytes, a concept originally in-
troduced by Burnet (2). Therefore, when compared with a
naive host, a primed host responds to a secondary antigenic
exposure more effectively simply because more antigen-reactive
cells are present (3) .
In addition to stimulating the expansion of antigen-reactive
clones, the primary exposure to antigen has also been thought
to initiate a permanent qualitative change in the cells. For
example, B cells respond to antigen priming by undergoing
molecular genetic changes that result in their differentiation
to secretory cells, recognized morphologically as a change
to a plasma cell phenotype. In addition, due to genetic recom-
bination and deletion events, Ig H chain class switching occurs,
resulting in a permanently differentiated genotype (4). Also,
as a result of somatic hypermutation of V region genes, affinity
maturation of the antigen-binding region takes place, ulti-
mately resulting in the preferential selection and persistence
of those cells secreting antibodies with the highest affinities
(5, 6). As a consequence of these findings, the concept of
B cell memory no longer includes only the quantitative ex-
pansion of specific B cell clones, but has progressed to a mo-
lecular genetic definition of a truly differentiated memory cell.
By comparison, T cell memory has thus far eluded a simi-
larly distinctive molecular genetic analysis due to two fun-
damental experimental problems. First, it has been impos-
sible to unequivocally discriminate between the cells
responsible for the characteristic features of the naive and
memory immune responses. Second, the molecules involved
in T cell effector functions had not been identified until re-
cently. Consequently, putative naive and memory T cell popu-
lations could not be prepared in sufficient quantity and pu-
rity to allow the application of biochemical and molecular
genetic approaches that might delineate qualitative differences
between them.
More recently, several investigators have made use ofpheno-
typic markers to define the cellular compartment in adult
peripheral blood that contains memory T cells. For instance,
the T cell subsets identified by CD45RO, CD29, or CD58
have been shown to have adhesion and activation characteris-
tics that are consistent with the concept of an accelerated sec-
ondary recognition event during a memory response (7-13).
However, there is no way of knowing whether the subset
defined by the absence of these putative memory markers is
truly antigenically naive, particularly since adults have been
exposed repeatedly and over a long period of time to a myriad
of antigens in the environment . Functional comparisons be-
tween T cell subpopulations derived from the blood of im-
munologically experienced individuals and separated on the
basis of theirdifferential expression of these phenotypic markers
may therefore not necessarily measure naivete vs. memory.
Indeed, an alternative interpretation of the dissimilarities found
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CD45 isoform markers more appropriately distinguish be-
tween functionally diverse T cell subsets that evolve and per-
sist as independent lineages (14-16).
To circumvent the uncertainties inherent in trying to identify
and separate naive and memory T cells from adult blood,
we have made use ofa biological distinction between naivete
and memory and drew on the naturally occurring sources
of the beginning and endpoints of the development of im-
munity. In this regard, neonatal T cells derived from umbil-
ical cord blood are naive with respect to antigenic stimula-
tion and represent a population of truly unprimed cells. By
comparison, T cells derived from adult peripheral blood have
had ample antigenic exposure and were used as a source of
in vivo primed cells that have acquired "memory".
With regard to a molecular characterization of T cell im-
mune responsiveness, it is now established that T cell-de-
rived lymphokines actually execute the cellular and molec-
ular reactions that ultimately are recognized as cellular
immunity: T cell proliferation, T cell help for B cell prolifer-
ation and antibody secretion, as well as the recruitment and
activation of macrophages and leukocytes have all been as-
signed to distinct lymphokines (17). Moreover, sensitive assays
are now readily available to detect all of these molecules.
Thus far, most studies directed toward uncovering func-
tional disparities between naive and memory T cells have fo-
cused on potential differences in activation parameters (18-20).
However, by analogy to the genetic differentiation process
ofB cell memory, we hypothesized that a fundamental func-
tional distinction between naive and memory T cells might
arise by differences in the expression ofdistinct genes, partic-
ularly those encoding the mediators of cellular immunity.
Accordingly, we examined gene expression for a variety of
lymphokines by taking advantage of the PCR as a highly
sensitive method to detect mRNA transcripts (21-23) . Our
results, reported here, indicate that the differential capacity
to express lymphokine genes underlies and determines the
marked functional difference between unprimed and primed
T cells. Moreover, during the course of these studies, we have
developed the cellular and molecular methods to permit one
to investigate the mechanisms responsible for this acquisi-
tion of an extended lymphokine repertoire.
Materials and Methods
Antibodies
T cell activation was performed using 64.1, an IgG2a mAb
directed against CD3 (from Dr. Ellen Vitetta, Dallas, TX). Affinity-
purified goat anti-mouse IgG (Fc specific) was purchased from Or-
ganon Teknika, West Chester, PA. For indirect fluorescent staining,
the following mAbs were used at saturatingconcentrations: aT11
(clone 3PT2H9), reactive with CD2 (from Dr. Ellis Reinherz,
Boston, MA); OKT3, OKT4, and OKT8, reactive with CD3,
CD4, and CD8, respectively (Ortho Pharmaceuticals, Raritan, NJ);
N901 and 3118, IgG and IgM, respectively, directed against CD56
(from Dr. Jerome Ritz, Boston, MA); Bl, reactive with CD20
(Coulter Immunology, Boston, MA); 3C10, reactive with CD14,
and 9.3C9, reactivewith HLADR and DQ (from Dr. GillaKaplan,
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New York); 1HT4, reactive with CD25 (from Dr. Ellis Reinherz,
Boston, MA). Rabbit anti-mouse FITC conjugate was from Zymed
Laboratories, San Francisco, CA, and was used at 1:50 final dilu-
tion. Human gamma globulins used to block nonspecific FcR-
mediated staining were purchased from Organon Teknika.
Cell Culture Reagents
Complete medium consisted of RPMI 1640 (Gibco Laborato-
ries, Grand Island, NY) supplemented with 50 U/ml penicillin,
50 14g/ml gentamycin, 200 Eag/ml L-glutamine, and 10% heat-
inactivated calf serum (HyClone Laboratories, Logan, UT). Ho-
mogeneous rIL2 was obtained from Takeda Chemical Industries,
Osaka, Japan, and supplied as a 1-mg/ml solution in 5 mM ammo-
nium acetate buffer (pH 5). In some experiments, 10 /AM aphidicolin
(Sigma Chemical Co., St. Louis, MO) was used to completely in-
hibit [3H]TdR incorporation.
Cell Purification
Umbilical cord blood was collected in preheparinized syringes
from healthy full-term neonates immediately after vaginal delivery.
Adult blood was drawnfrom healthy volunteers. Mononuclear cells
were isolated by means of Ficoll-Hypaque discontinuous gradient
centrifugation. In some instances, heavy red cell contamination of
umbilical cord mononuclear cells necessitated further purification
by centrifugation over a 65% Percoll (Pharmacia LKB Biotech-
nology, Piscataway, NJ) gradient. Interface cells were washed three
times in normal saline and incubated at a final concentration of
5 x 106 cells/ml in 5 MM L-leucine-methyl-ester hydrochloride
(Sigma Chemical Co.), in serum-free medium at room tempera-
ture for 45 min. This procedure has been shown to effectively elim-
inate monocytes and a large proportion of NK cells (24, 25). The
cell mixture was centrifuged at 450 g for 20 min over a 43.5%
Percoll gradient to separate dead cells and residual low density NK
cells and macrophages from the high density lymphocytes, as de-
scribed (26). The cell pellet was washed twice in completemedium,
and to eliminate residual Fc-Receptor positive cells, N5 x 10' cells
were incubated in a final volume of 2.5 ml for 20 min at 37*C
in 100-mm bacteriological petridishes (Fisher Scientific Co., Pitts-
burgh, PA) that had been coated with 10 mg/ml human gamma
globulins in PBS immediately before use; nonadherent cells were
then collected and the procedure repeated once. The remainder of
the cells were incubated for 45 min at 37°C at a maximum concen-
tration of 2.5 x 107 cells/ml in Lympho-Kwik TH (One Lambda,
Los Angeles, CA), to which 3138 (ceCD56 mAb) was added to give
a final dilution of 1:100 of ascites. Treatment with this cocktail
of mAbs and complement selectively lyses HLA-DR* cells, B
cells, residual granulocytes, NK cells, and CD8* cells. A final den-
sity centrifugation was performed to separate the dead cells, and
the cell pellet was washed twice in complete medium.
Assessment of Cell Purity
Cells at different stages of purification were incubated with
saturating concentrations of mAbs specific for various surface
markers for 60 min on ice. Indirect fluorescent staining was per-
formed with 1:50 dilution of rabbit anti-mouse Ig FITC for 60
min on ice. Cells were then fixed in 2% paraformaldehyde-PBS
until evaluation by FACScan (FRCS is a registered trademark of
Becton Dickinson & Co.).
Umbilical cord blood mononuclear cells from density centrifu-
gation were 58-70% CD2 * , 44-65% CD3* , 25-39% CD4* ,
9-21% CD8*, 6-15% CD56*, 7-10% CD20', 10-20% CD14*,and 18-20% HLA-DR*. Umbilical cord blood cells purified by
L-leucine-methyl-ester, FcRpanning, andmodified Lympho-Kwik
TH were 97-99% CD2*, 96-99% CD3*, 95-98% CD4*, and
0-1% CD8*. Staining for B cells, NK cells, monocytes, and HLA-
DR* cells was undetectable abovebackground control levels. Less
than 1/1,000cellsstained positive fornonspecific esterase (a-naph-
thyl-acetate esterase; Sigma Chemical Co.). These highly purified
umbilical cord blood-derived Th cells are referred to as neonatal
T cells in the text.
Adult peripheral bloodcellspurified by L-leucine-ester, FcRpan-
ning, and modified Lympho-Kwik TH were 95-98% CD2*,
95-98% CD3*, 95-98% CD4*, 0-1% CD8*, and did not ex-
press detectable CD14, CD20, CD56, or HLA-DR. Less than
1/1,000 cells stained positive for nonspecific esterase. These cells
are referred to in the text as adult T cells.
Cell Stimulation and Culture
96-well, flat-bottomed tissue culture plates (Corning Glass
Works, Corning, NY)were coated with 50,ulof a20-Wg/ml solu-
tion of goat anti-mouse IgG (Fc specific) in Tris-HCI (pH 9.5)
forat least3 h at room temperature. Immediately before use, wells
were washed three times with normal saline.Unless indicatedother-
wise, cells were added to the wells at a final concentration of 2
x 105/well in the presence of 1 pg/ml 64.1 ot-CD3 mAb in com-
plete medium. This procedure of crosslinking the CD3 structure
is referred to throughout the text as stimulation via a-CD3. For
further expansion, cells were harvestedafter48 hbyvigorous pipet-
ting and incubated at densities not exceeding 106/ml in complete
medium containing saturating amounts of rIlr2 (1 nM). On the
day of restimulation, cells were washed twice, incubated at 37°C
for 45 min, and washed once more to remove residual rIL2. Sec-
ondary stimulation was performedidentically to primarystimula-
tion. In some experiments, the following mitogens were used to
activate thecells: 1 hg/mlPHA (Wellcome, Research Triangle Park,
NC) or 11AM Ionomycin (Calbiochem-Behring Corp., SanDiego,
CA) with 5 ng/ml PMA (Sigma Chemical Co.).
Thymidine Incorporation
After24-72 h in culture, DNA synthesiswas assessed by adding
0.5 p,Ci/well ['H-methyl]thymidine (10 Ci/mmol; ICN Biochem-
icals, Irvine, CA) for the final 2 h of culture. Triplicate cultures
were harvestedonto glass fiber filters, andradioactivity wascounted
by liquid scintillation. Underthe specified conditions peak prolifer-
ation occurred at 48 h. ['H]TdR incorporation was calculated as
cpm/10" cells/h.
Measurement of 11,2, IFN-y and Granulocyte/Macrophage
CSF (GM-CSFY
Supernatants of stimulated cells were harvested after indicated
time intervals, centrifuged to remove cells and debris, and stored
at -70*C untilprotein determinations were performed. IL2 con-
centrations were determined by the CTLL2 bioassay as described
(27). INF-y and GM-CSF concentrations were determined by
specific ELISA (Endogen, Boston, MA). ELISAs were performed
exactly as specified by the manufacturers, and protein concentra-
tions arelisted in picomoles. The limits of detection were 2.5 pM
for INF-y and 1 pM for GM-CSF.
1 Abbreviation used in this paper: GM-CSF, granulocyte/macrophage colony-
stimulating factor.
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PCR-assisted mRNA Amplification
Preparation ofcDNA.
￿
Total RNA preparation was performed
essentially as described (28). In brief, afterindicated time intervals,
supernatants were removed from themicrotiter wells, andice-cold
PBS was added. Cellswere removedby steady pipetting andwells
were inspected for complete cell recovery. Cells were counted
(Coulter Electronics Inc., Hialeah, FL) and aliquoted to
106/Eppendorf tube (1.5 ml), pelleted for 10 s in a table-top Ep-
pendorfmicrocentrifuge (Brinkmann Instruments Co., Westbury,
NY), andlysedin 500 itllysis solution, consisting of4Mguanidine-
thiocyanate (Boehringer Mannheim Biochemicals, Indianapolis, IN),
25 mM Na-citrate (pH 7), 0.5% N-lauroylsarcosine (Sigma Chem-
ical Co.), and 100mM 2-ME (Sigma Chemical Co.). Lysates were
prepared at leastin duplicate, vortexed, and stored at -70°C until
further processing. After thawing, 50 Al of 2 M Na-acetate (pH
4.0), 500 lil of water-saturated acid phenol (Bethesda Research
Laboratories, Bethesda, MD), and 100 tcl of chloroform-iso-amyl
alcohol (49:1) were added to the lysates with thorough vortexing
after each addition. The mixture was then chilled on ice for 15
min and spun at 10,000 g for 15 min at 4°C. The aqueous phase
was recovered and RNA was precipitated in an equal volume of
2-propanol at -20°Cfor at least90 min. Precipitates were pelleted
at 4°C, washed once with 75% ethanol in diethylpyrocarbonate-
treated double-distilled water (DEPC-ddH20) and repelleted at
4°C at 10,000gfor 15 min. Vacuum-dried pellets were resuspended
in 10 p.l DEPC-ddH20 containing 2 ug oligo-dT (12-18 mer;
United States Biochemical Corp., Cleveland, OH) and incubated
at 65*C for10 min. Aftercoolingon ice, themixturewasincubated
with 10 ttl of 2x RTbuffer (100 mM Tris-CI, pH 8.3, 150 mM
KCL, 6 mM MgCl2, 20 mM DTT) and final concentrations of
200U of MMLV reversetranscriptase (Bethesda Research Labora-
tories), 1 mM dNTPs(United States Biochemical Corp.), 100Ftg/ml
acetylated BSA (Sigma Chemical Co.), and 25 U of RNAsin
(Promega Biotec, Madison, WI) for 60 min at 37°C. Tubes were
then heated to 95°C for 5-10 min, and 80 P.1 of dH20 was added
to the 20-P1 reaction mixture. Samples were stored at 4*C until
further use. RT reactions were performed simultaneously for ly-
sates derived from adult and neonatal blood.
PCR Conditions.
￿
Lymphokine-specificprimer pairsIL-2, -3, -4,
-5,-6,IFN-y, and0-Actin(Y) were purchased(Clontech, Palo Alto,
CA) or synthesized on a Cyclone DNA synthesizer (Biosearch,
San Rafael, CA) and purified using NENSORB PREP columns
(DuPontCo., Wilmington, DE): 0-actin (5'), ILl0, GM-CSF, and
IL-2R p55. Sequences are specific as ascertained by computer as-
sisted search of updated versions of GenBank. 5' and 3' primers
were complementary to sequencesin thefirst andlast exons, respec-
tively, or spanned exon-exonjunctions and are therefore mRNA
specific. 5' primers were designed to recognize sequences no far-
ther than 1,250by upstream ofthepolyT tract ofthe cDNA. The
control 0-actin 5' primer recognizes asequenceexactly 1,252-1,222
by upstream. Primer sequencesareshownin Fig. 1. In preliminary
experiments, 10-fold serial dilutions of irrelevant DNA (A-phage)
were performedinto cDNA samples from both adult andneonatal
Tcellsandsubjected to 25 cycles ofPCRusingprimersamplifying
a 500-bp fragment (GeneAMP kit; Perkin-Elmer Cetus, Emeryville,
CA). The limit of detection was determined to be in the order
of 10^ molecules whose amplification product couldreproducibly
be visualized as afaintband after gelelectrophoresis. Subsequently,
5 pl of cDNA (representing RNA derived from 5 x 10° cells to
ensure a sensitivity of detection of at least one molecule per cell,
allowing for losses during RNA preparation and reversetranscrip-
tion)was amplified in 0.5 ml GeneAmp reaction tubes (Cetus Corp.,Emeryville, CA) in the presence of 200 nM final concentrationof
5' and3' primers, 200AM dNTPs, 0.5 U ofTaqpolymerase (Cetus
Corp.), and PCR buffer containing 2.5 AM MgC12, 50 mM KCL,
10 mM Tris-CI (pH 8.3), 4nd 0.001% gelatin in a final volume
of 25 Al. The reaction mixture was overlaid with a drop of light
mineral oil, and PCR was performed in a DNA thermal cycler
(Cetus Corp.) for 25 cycles: 45-s denaturation at 94°C, 45-s an-
nealing at 60°C, and 1.5-min extension at 72°C. The reaction
product was visualized by subjecting to electrophoresis 20 Al of
thereaction mix at 80 V for 70 minin 2% agarosein 0.5x TBE
buffer containing 0.5 Ag/ml ethidium bromide. 1 Ag of HaeIII-
digested Ox174 DNA (Clontech) was run in parallel as molecular
weight markers (providing bands at 1,353, 1,078, 872, 603, 310,
281, and 234 bp). Specificity of the amplified bands was validated
by their predicted size and restriction enzyme digests giving ap-
propriately sized fragments. PCRassisted mRNA amplification was
repeated at least once for each RNA sample, and has been per-
formed on six separate samples from adult T cells and >25 sepa-
rate primary and secondary preparations from neonatal T cells to
date, yielding identical results to the ones described in Results.
Results
Activation ofNeonatal TCellsvs.AdultTCells.
￿
To meaning-
fully compare functional parameters of neonatal and adult
Tcells, it was important to ensure that both cell populations
couldbe activated maximallyandequally. To do so, we capital-
ized on the finding of Geppert and Lipsky (29) that purified
T cells can be efficiently stimulated after depletion of acces-
sory cellsby crosslinking solely theTCR/CD3complex, the
cx-CD3 mAb 64.1 being particularly potent. A comparison
of the concentrations ofcx-CD3 required to activate neonatal
and adult purified CD4+ T cells when crosslinked via an
immobilized bridging antibody is shown in Fig. 2. In three
separate experiments, there were no differences in theresponse
thresholds of neonatal vs. adult T cells, so that an optimal
dose of 1 Ag/ml ci-CD3 was chosen for all subsequent ex-
periments.
Several approaches were used to evaluate whether activa-
tion by ci-CD3 delivered equally potent signals to the two
cell populations via the TCR/CD3 complex. First, IL -2
production was monitored and found to be comparable (neo-
natal T cells: 40.3 ± 22 PM vs. adult T cells; 43 .3 ± 21
pM, n = 8). Second, IL-2R expression as measured by using
IL-2R ci-p55 mAbs and flow cytometry showed equivalent
and maximal levels after 72 h of culture, in that >97% of
thecells stained positive. Third, consistent with these findings,
proliferation monitored by [3H]TdR incorporation was com-
as
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Figure 2.
￿
Proliferation of neonatal (0)andadult(*) Tcells after 48 h
of activation with various doses of tx-CD3 crosslinked via immobilized
goat anti-mouse IgG. [3H]TdR incorporationwas assessed during thelast
2 h of culture. Data are from an experiment representative of three per-
formed. The SD of triplicate cultures were always <10%.
Size of
Amplified
mRNA 5' Sense Primer 3' Antisense Primer Fragment
(b p)
-Actin 5'-TGACGGGGTCACCCACACTGTGCCCATCTA3' 5'-CTAGAAGCATTGCGGTGGACGATGGAGGG3' (661bp)
IL-1P 5'-CTTCATCTTTGAAGAAGAACCTATCTTCTT-3' 5'-AATTTTTGGGATCTACACTCTCCAGCTGTA-3' (331bp)
IL-2 5'-ATGTACAGGATGCAACTCCTGTCTT-3' 5'-GTCAGTGTTGAGATGATGCTTTGAC-3' (458 bp)
IL-3 5'.ATGA000GCCTGCCCGTCCTG-3' 5'-GCGAGGCTCAAAGTCGTCTGTTG-3' (449 bp)
IL-4 5'-ATGGGTCTCACCTCCCAACTGCT-3' 5'-CGAACACTTTGAATATTTCTCTCTCAT-3' (456 bp)
IL-S 5'-GCTTCTGCATTTGAGTTTGCTAGCT-3' STGGCCGTCAATGTATTTCTTTATTAAG-3' (291 bp)
IL-6 5'-ATGAACTCCTTCTCCACAAGCGC-3' 5'-GAAGAGCCCTCAGGCTGGACTG-3' (628 bp)
IFNy 5'-ATGAAATATACAAGTTATATCTTGGCTTT-3' 5'-GATGCTCTTCGACCTCGAAACAGCAT-3' (501 bp)
GM-CSF 5'-ACACTGCTGAGATGAATGAAACAGTAG-3' 5'-TGGACTGGCTCCCAGCAGTCAAAGGGGATG3' (286 bp) Figure 1 . Primer sequences used
for PCR-assisted mRNA ampli-
IL-2R p55 5'-TTATCATTTCGTGGTGGGGCAGATGGTTTA-3' 5'-TCTACTCTTCCTCTGTCTCCGCTGCCAGGT3' (391 bp) fication.0 .
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Figure 3 . Proliferation of neonatal and adult T cells and neonatal
mononuclear cells using various stimuli . (1) Adult T cells (n = 10) stimu-
lated with 1 Fog/ml soluble a-CD3 ; (2) neonatal T cells (n = 41) stimu-
lated with 1 Wg/ml soluble a-CD3 ; (3) adultT cells (n = 10) stimulated
via crosslinked a-CD3 ; (4) neonatal T cells (n = 41) stimulated via cross-
linked a-CD3 ; (5) neonatal T cells (n = 6) stimulated with 1 Fog/mlPHA
and 5 ng/ml PMA; (6) neonatal mononuclear cells (n = 8) stimulated
with 1 )cg/ml PHA. Background [ 3H]TdR incorporation ± SD was 5.3
± 2 cpm/104/h for neonatal T cells, 2.9 ± 1 for adult T cells, and 9.5
± 1 for neonatal mononuclear cells. [3H]TdR incorporation was assessed
48 h after activation during the last 2 h ofculture . Error bars represent 1 SD.
parable in the two populations when measured at the peak
of the response, which occurred after 48 h of culture (Fig .
3) . As an additional test to ascertain whether neonatal T cells
were optimally activated, PHA was used in place ofa-CD3 .
Figure 4 .
￿
IFN-.y (top) and GM-CSF (bottom) concentrations in super-
natants of stimulated neonatal and adultT cells . Supernatants were har-
vested 24 and 48 h after activation via a-CD3 . Protein determinations
were performed by specific ELISAs . (1) Neonatal T cells, 24 h (n = 25) ;
(2) neonatal T cells, 48 h (n = 25) ; (3) adult T cells, 24 h (n = 10) ;
(4) adult T cells, 48 h (n = 10) . Error bars represent 1 SD .
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However, as the purified T cells did not proliferate in response
to PHA, total mononuclear cells stimulated with PHA had
to be compared with purified T cells stimulated with PHA
and PMA . Maximal [ 3H]TdR incorporation occurred after
48 h and was found to be similar for all experimental groups
(Fig . 3, columns 5 and 6) .
Production ofIFN-,y and GM-CSF during Primary Stimula-
tion. Having ensured equivalent activation results as defined
by IL2 production and responsiveness, the secretion ofIFN--y
and GM-CSF was monitored after 24 and 48 h of culture.
As reported previously by Bryson et al . and Wilson et al .
(30, 31), and shown in Fig . 4 (top), neonatal T cells did not
produce IFN-.y , even though adult T cells secreted readily
detectable amounts. NeonatalT cell GM-CSF production also
was undetectable after 24 h of culture in 24 of 30 samples
examined, and at the limit of detection (1-1.7 pM) in the
remaining six samples. (Fig. 4, bottom) . By comparison, adult
T cells secreted GM-CSF by 24 h and even higher levels by
48 h . It is noteworthy that in contrast to IFN--y secretion,
neonatal T cell supernatants also contained GM-CSF when
tested at 48 h . Therefore, neonatal T cells seem capable of
mounting aGM-CSF secretory response, although it is delayed
compared with the adult T cell response. In separate experi-
ments (not shown), we have found the induction of GM-
CSF secretion to be entirely IL-2 dependent .
Lymphokine Gene Expression Detected by PCR-assistedmRNA
Amplification. Since our methods ofTCR/CD3 triggering
resulted in equivalent activation ofneonatal and adult T cells
as monitored by 11,2 production, yet resulted in deficient
IFN-y and GM-CSF secretion, it appeared as though neo-
natal T cells might be unable to express some lymphokine
genes. Therefore, to examine lymphokine gene expression more
comprehensively, thePCR technique was chosen to provide
the most sensitive assay for the presence or absence ofmRNA .
As shown in Fig. 5, before in vitro activation, both neonatal
T cells and adult T cells were devoid ofmRNA for any of
the lymphokines tested . In contrast, as shown in Fig . 6, adult
T cells contained readily detectable levels ofmRNA for IL-2,
Figure 5 .
￿
PCR-assisted mRNA amplification of adult (top) and neo-
natal (bottom) T cells immediately before stimulation .Figure 6 .
￿
PCR-assisted mRNA amplification of adult (top) and neo-
natal (bottom) T cells 3 h after primary activation via u-CD3 .
IL-3, IL-4, IL-5, IFN-y, GM-CSF, and IL-2R p55 as early
as 3 h after stimulation . By comparison, neonatalT cells only
expressed detectablemRNAs for IL-2 and the IL-2R p55 chain
at this time interval .
To examine the kinetics of lymphokine mRNA expres-
sion, cells were harvested after 3, 6, 9, 24, and 48 h ofstimu-
lation . Adult T cells showed the same lymphokine expres-
sion profile throughout the study period (Fig . 7), IL-6mRNA
being only faintly detectable and only after prolonged cul-
Figure 7.
￿
PCR-assistedmRNA amplification ofadult T cells at various
times after stimulation via a-CD3 . From top to bottom : 6, 9, 24, and
48 h after activation .
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ture (24 h) . By comparison, neonatal T cells were incapable
of producing any of the lymphokines, with the notable ex-
ceptions of IL-2 andGM-CSF (Fig. 8) . GM-CSFmRNA was
reproducibly detected in neonatal T cells after 24 h of cul-
ture, and in some experiments it appeared as early as 9 h after
stimulation . However, the remainder of the lymphokines re-
mained undetectable up to 48 h of culture.
Lymphokine mRNA Expression in Response to Alternative
Stimuli. Some reports have indicated that naiveT cells might
have a higher activation threshold than primedT cells (18-20) .
Therefore, it was important to test alternative pathways of
stimulation to determine whether neonatal T cells were simply
stimulated suboptimally, or whether they were actually in-
capable of expressing most of the lymphokine genes. The
combinations ofPHA/PMA and Ionomycin/PMA at con-
centrations that resulted in optimal proliferation had no effect
on the inducibility of any ofthe lymphokine mRNAs tested
(Fig. 9) . Again, only 1172 and IL-2R p55 mRNAs were de-
tected under these conditions, thereby confirming the results
obtained using a-CD3 for stimulation .
Comparison ofNeonatal T Cells with Neonatal Mononuclear
Cells. Since theT cells were extensively purified before stim-
ulation, it was possible that cells exhibiting a lymphokine
profile typical of adult cells could have been lost during the
Figure 8 .
￿
PCR-assistedmRNA amplification of neonatal T cells at var-
ious times after stimulation via ct-CD3 . From top to bottom : 6, 9, 24,
and 48 h after activation .Figure 9.
￿
PCR-assisted mRNA amplification of neonatalT cells after
primary stimulation with PHA and PMA (top) or Ionomycin andPM
(bottom).
purification procedure. Alternatively, costimuli originating
from accessory cells might be necessary for neonatal T cells
to expresslymphokine genesotherthan 11,2 . Therefore, total
mononuclear cells were stimulated with 1 Fag/ml PHA and
tested forcytokine mRNA expression. As shown in Fig . 10,
the mRNAs for IIr3, IL4, IIr5, and IFN-y still remained
undetectable under these conditions, while IL-10, IL-6, and
GM-CSF mRNAs were easily amplified, as expected from
the presence of monocytes and NK cells.
The Differentiation ofNeonatalTCells In Vitra
￿
Thefore-
going experiments served to illustrate a distinct difference
between neonatal and adult T cells in their capacities to ex-
press lymphokine genes. However, this inability to express
lymphokine genes upon aprimarystimulation in vitro might
be explained simply by an immaturity on thepart of the neo-
natal cells . Consequently, it wascrucial to ascertain whether
the primary in vitro stimulation could actually mimic the
in vivo situation, promoting a switch, so that upon secondary
stimulation, an adult-type lymphokine repertoire could be
expressed. Therefore, neonatalT cells were stimulated as be-
fore for 48 h, then washed out ofa-CD3 and cultured with
Figure 10.
￿
PCItassisted mRNA amplification ofneonatal mononuclear
cells after 3 h of primary stimulation with PHA. Mononuclear cells were
prepared by a 65% Percoll-gradient centrifugation .
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a saturating concentration ofrIL2 . At varying intervals, the
cells were restimulated via ct-CD3 using the same protocol
developed for the primary stimulation .
After 7-10 d of culture, the cells cease proliferating, and
express no lymphokine mRNAs (Fig . 11, top) . Then, upon
restimulation via theTCR/CD3 complex, the in vitroprimed
neonatal T cells express within 3 h the mRNAs for all of
the lymphokines produced by adultT cells, with the excep-
tion of IIr5 . As shownin Fig . 11, adetailed time course after
restimulation revealed that IL5mRNA does appear, but only
after a lag period of ti9 h. It then persists along with the
other lymphokine mRNAs for as long as 48 h. Also, when
tertiary stimulation of neonatal T cells was performed, IL5
mRNA was apparent after 3 h. No lymphokine transcripts
were detected in the absence of restimulation. Also, when
IIr2wasreplenished without restimulation of the TCR/CD3
complex, only GM-CSF mRNA was apparent . Controlneo-
natalTcells placed only in medium andthen stimulated after
5 d via ot-CD3 still produced only IIr2 and IL2R mRNA,
in a fashion identical to neonatal cells that were stimulated
when freshly isolated . Moreover, the capacity to express an
extended lymphokine mRNA profile was also reflected in
thesecretionof thegene products : all supernatants harvested
24h after secondary stimulation contained readily detectable
levels ofIFN-'y (19.2 ± 4.1 pM, n = 25) and GM-CSF (71.4
± 7.8 pM, n = 25) .
Figure 11 .
￿
PCR-assisted mRNA amplification of secondary neonatal
T cells. Neonatal T cells were primarily stimulated with a-CD3and ex-
panded in rlIL2 for7d.From top to bottom: immediately before restimu-
lation, 3 h after restimulation via a-CD3, 9 h after restimulation, and
48 h after restimulation .The switch in the capacity to express the lymphokine genes
first becomes detectable after 3 d of culture and is stable for
as long as 14 d, after which the cells begin to die if not re-
stimulated. These results suggested that the switch couldnot
be explained by the selective outgrowth of a minor subset
of already differentiated cells present at the initiation of cul-
ture. However, to confirm this interpretation, neonatal T cells
were stimulated in the presence of aphidicolin to prevent DNA
replication. As aphidicolin specifically blocks DNA polymerase
I and II without affecting RNA synthesis or blastogenesis,
it is an ideal agent to prevent proliferation without overall
metabolic inhibition (32). After 5 d of stimulation in the
presence of aphidicolin, viable cells were recovered and re-
stimulated via ot-CD3. Again, a lymphokine profile typical
of differentiated T cells was detected.
Discussion
Primary antigenic exposure in vivo initiates changes in the
immune system that can ultimately lead to immunity. One
crucial feature of immunity is the capacity of the host to
"remember" the priming antigen, and thereby respond to
it more efficiently; this property of the immune system is
conventionally termed immunologic memory (1, 33) . The
precise nature of the events governing the acquisition of
memory in vivo has escaped direct experimental scrutiny, partly
because of the inaccessibility and complexity of the cellular
components involved. As a first step toward an adequate in
vitro representation of the processes determining T cell
memory, we devised a simple experimental model system that
makes use of the biologically defined cellular sources of na-
ivete and memory, yet applies a reductionist approach with
respect to T cell activation and the measurement of T cell
responsiveness. This in vitro system demonstrates a clear
qualitative difference between unprimed and primed T cells,
in that antigenically virgin cells can respond to activation
by proliferating, yet cannot secrete effector lymphokines other
than IL2. By comparison, antigenically experienced cells are
shown to be capable of expressing many, if not all, of the
lymphokines involved in an immune/inflammatory response
immediately upon stimulation. Most important, naive T cells
can and do respond to a primary in vitro activation by a
differentiation process, which then enables them to express
the entire repertoire of effector lymphokines immediately upon
subsequent restimulation. Therefore, this in vitro system of
T cell differentiation mimics the accelerated nature and func-
tional superiority ofthe in vivo anamnestic immune response.
It should be emphasized that the early studies by Tedder
et al., (34, 35) comparing putative naive and memory T cell
subsets separated from adult blood found that memory cells
could provide help for the generation of antibody-forming
cells, while naive T cells were deficient in this regard. How-
ever, at this time, T cell help had not yet been ascribed to
distinct lymphokines, so that it was impossible to proceed
to a molecular dissection ofthe phenomenon. Subsequently,
Sanders et al. (7, 18), Salmon et al. (36), and Lewis et al.
(37) did examine the production of lymphokines, notably
IFN-y and IL4, and found that the putative naive cell subset
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was deficient in both the mRNA expression and the secre-
tion of these lymphokines relative to the putative memory
cell subset. Separate studies by Lewiset al. (38) using Northern
blot analysis to examine INF-y mRNA expression by neo-
natal T cells supported the impression that antigenically naive
T cells were somehow defective in their capacity to respond
to stimulation by the production ofat least some lymphokines.
However, the mechanism underlying such a functional de-
ficiency has remained controversial and ill defined, and thus
far, it has not been approached with a molecular genetic hy-
pothesis in mind. Rather, most investigators have focused on
uncovering differences in the activation parameters between
naive and memory T cells, and have not directly posed the
question as to whether primed T cells might differ from un-
primed T cells qualitatively by their ability or inability to
express multiple effector lymphokine genes.
To devise an experimental approach that would allow an
unambiguous interpretation of the results in terms of gene
expression, several conceptual and technical problems had to
be taken into consideration.
(a) It was crucial to begin the analysis with -a homoge-
neous population of antigenically virgin T cells, since any
contamination of the naive T cells with already primed cells
would have precluded a meaningful analysis. However, the
exact cellular compartments responsible for memory and na-
ivete have remained uncertain, so that it has been difficult
to identify representative cell subsets in adult blood and to
separate them from one another. In this regard, several pheno-
typic markers have recently been proposed to distinguish be-
tween naive and memory T cells. For instance, it has been
shown that the T cell subsets defined by CD26, CD29,
CD45RO, or CD58 are capable of responding to recall an-
tigens and therefore, by definition, contain memory T cells
(7-9). A number of investigators have made use of these
markers to separate cellsand have reported differences in acti-
vation parameters and functional and phenotypic character-
istics of the subsets obtained (7, 10, 18-20, 36, 37, 39-43).
A distinct disadvantage of this strategy lies in the inevitable
crosscontamination with the reciprocal subset, which essen-
tially precludes the application of sensitive molecular genetic
approaches that might detect the products of those few con-
taminating cells. In addition, the marker CD45RO, for ex-
ample, does not per se qualitatively delineate "memory", since
many other cell types of the hematopoietic lineage express
it, including immature thymocytes (44, 45). Accordingly, to
circumvent the ambiguities inherent in identifying and separ-
ating putative naive and memory T cells in adult blood, we
capitalized on the only known natural source of purely naive
cells, those found in newborns. By definition, neonatal T cells
derived from umbilical cordblood represent a population com-
prised primarily of virgin T cells, in that antigenic exposure
in utero is rare. This state of functional immune naivet6 is
reflected in the fact that neonates are less efficient than adults
at mounting an effective immune response to a variety of
infectious agents (46). By comparison, a considerable propor-
tion of T cells derived from adult blood have memory, in
that normal individuals have had extensive exposure to en-vironmental microbes and have developed long-lasting im-
munity to most infectious agents.
(b) To interpret any differences in the lymphokine gene
expression between neonatal and adult T cells as attributable
to the T cells themselves, it was critical to rigorously purify
them from contaminating granulocytes, B cells, monocytes,
and NK cells, which are also knownto produce some cytokines
(47-49).
(c) In view of several reports that have suggested that neo-
natal monocytes are relatively immature or might even have
suppressive effects, it was important to use a system depleted
of accessory cells (50, 51) . Moreover, Inaba and Steinman (52)
have provided evidence that unprimed and primed T cells
have distinct requirements for APC. As well, phenotypic
studies have suggested that primed cells have a higher den-
sity ofa number of activation molecules on their surface (10,
11). Most of these molecules facilitate cell-cell interaction,
while some have also been implicated in auxiliary signaling.
Since most of these structuresfind theircounterparts on mono-
cytes, it has been suggested that a complex of triggering mol-
ecules involving the TCR and these accessory structures is
more easily formed with primed than unprimed cells (11, 53).
Thus, only an accessory cell-depleted system avoids the ex-
perimental ambiguity and difficulties in the interpretation of
results that arisewhen stimulation is performed in the pres-
ence of monocytes and other non-T cells.
(d) Some investigators have emphasized that primed T cells
express a higher density of ancillary molecules, such as CD2,
CD18/CD11a, CD28, CD29, CD44, CD54, CD58, etc., con-
tributing to their lower threshold for activation (8, 11, 53,
54). Therefore, to compare neonatal and adult T cells meaning-
fully, it was mandatory to devise an efficient and equal system
for activating the cells, one that functioned solely via a trig-
gering structure present in equal densities on both popula-
tions, and one that would be indifferent to any dissimilarities
in T cell accessory molecules. This was accomplished by cross-
linking exclusively the CD3/TCR complex via immobilized
ci-CD3, which has been shown to be an effective stimulus
for T cells even in the absence of accessory cells (29).
(e) It was necessary to demonstrate that the signals trans-
duced through the TCR/CD3 complex were equivalent for
both neonatal and adult T cells, particularly sinceseveral reports
have implied that neonatal T cells are somehow immature
(55-59). When monitored by IL2/IL2R-mediated prolifer-
ation, crosslinking with a-CD3 yielded similar results with
identical ot-CD3 dose-response relationships for both neo-
natal and adult T cells (Figs. 2 and 3) . Moreover, when trig-
gering via the TCR/CD3 complex was bypassed entirely using
phorbol ester and calcium ionophore, identical lymphokine
patterns were observed as with a-CD3-mediated activation
(Fig. 9). Therefore, in this experimental activating system,
it is unlikely that differential lymphokine mRNA expression
by neonatal and adult T cells is attributable to differing acti-
vation thresholds or due to differences in known intracel-
lular signal transduction pathways.
(f) To implicate a switch in gene expression, it was im-
portant to use a sensitive method such as the PCR to mon-
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itor mRNA expression (21-23). The particularreaction condi-
tions chosen were designed to detect as few as one mRNA
molecule/cell, given that all the cellsin the populationunder
study were responding to activation. Within these limits of
detection, neonatal T cells expressed easily detectable levels
of IL -2 and IL2R p55 mRNA transcripts, yet did not ex-
press any of the other lymphokines tested for. Therefore, at
this sensitivity level, it can only be concluded that the vast
majority of neonatal CD4+ T cells cannot express the genes
encoding most of the T cell lymphokines upon only a pri-
mary stimulation.
Finally, having uncovered a fundamental differencebetween
neonatal and adult T cell lymphokine gene expression, it was
obligatory to demonstrate that a primary stimulation of neo-
natal T cells would lead to their differentiation in vitro, al-
lowing them to express an adult-type lymphokine pattern
upon restimulation. Otherwise, the lack of the capacity to
express the majority of lymphokine genes could have been
interpreted as merely a sign of immaturity on the part of
the neonatal T cells. As secondary stimulation of neonatal
T cells did result in the expression of a lymphokine reper-
toire typical of T cells exposed to antigenic stimulation in
vivo, our data support the interpretation that neonatal T cells
really are mature: they can respond to TCR/CD3 activation
in vitro by proliferating, and also by differentiating to fully
competent, lymphokine-secreting effector cells. It is impor-
tant to note that our data are derived from whole cell popu-
lations and therefore contribute no information as to func-
tions of single cells. However, it is worthy of emphasis that
all attempts to demonstrate clonal segregation or restriction
of lymphokine gene expression by humanT cell clones similar
to that reported with murine T cell clones have failed to date
(36, 60-62) .
When considering the nature of a primary immune re-
sponse compared with an anamnestic response, our results
are consistent with the characteristics of the phenomenon
recognized in vivo as immunologic memory. Thus, if our
in vitro findings are reflective of what actually occurs upon
introduction of antigen in vivo, the first several days are taken
up by the IL-2-promoted clonal expansion of lymphocytes.
Assuming that antigen persists during this period, the ex-
panded clones of naive T cells that have undergone the differen-
tiative switch would then be capable ofreceiving a secondary
stimulation from persisting antigen. Ultimately, the secre-
tion of the rest of the lymphokines would direct the recruit-
ment and activation ofthe remainder ofcells that participate
in a fully developed immune response. By comparison, a
previously primed host that already has an expanded antigen-
experienced population is capable of secreting all of the
lymphokines immediately upon antigenic stimulation. Con-
sequently, the tempo of the anamnestic response is more rapid
compared with a primary response because of two fundamental
differences in the T cell populations: a primed host has an
expanded number of antigen-reactive cells, and these cells are
already differentiated so that they can release all ofthe immune-
inflammatory lymphokines immediately after antigen trig-
gering.With respect to additional mechanisms thought to be in-
volved in the phenomenon ofimmunologic memory, several
studies have indicated that memory cells also differ from naive
cells in their tissue distribution and recirculation patterns (12,
13, 63) . These characteristics may help explain the observed
rapid accumulation of primed cells at inflammatory foci and
may also contribute to the known longevity ofcell-mediated
immunity (11-13). Furthermore, the response to antigen
during a secondary exposure may begin more rapidly because
primed T cells may be more sensitive to lower antigen con-
centrations (10, 11, 18-20). However, in addition to these
characteristics of memory, the data presented here imply that
much of the functional superiority of the anamnestic immune
response lies in the differentiated state of a primed T cell that
enables it to immediately secrete precisely those effector lym-
phokines that are required for a full-fledged, coordinate im-
mune defense.
From the way our in vitro experiments were planned and
performed, differences in activation thresholds, known sig-
nalling pathways, and accessory cell contributions could be
excluded as responsible for the two distinct functional T cell
phenotypes. Instead, all of our data are consistent with the
interpretation that by analogy to B cells, T cellsalso undergo
an activation-dependent differentiationevent that permits their
secretion of multiple effector lymphokines upon restimula-
tion. Accordingly, we propose that the term "memory T cell"
be reserved for those T cells identified by their differentiated
state of lymphokine gene inducibility. T cell memory thus
entails not only the clonal expansion of specific T cells, but
also encompasses a differentiation event that allows additional
lymphokine gene expression.
This tentative definition provides for a testable working
hypothesis of T cell memory. In particular, it can now be
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